Peripheral Serum Exosomes Isolated from Patients with Acute Myocardial Infarction Promote Endothelial Cell Angiogenesis via the miR-126-3p/TSC1/mTORC1/HIF-1α Pathway

References

• Virani SS, Alonso A, Aparicio HJ, et al. Heart disease and stroke statistics-2021 update: a report from the American heart association. Circulation. 2021;143(8):e254–e743. doi:10.1161/CIR.0000000000000950
   PubMed Web of Science ®Google Scholar
• Zhu W, Sun L, Zhao P, et al. Macrophage migration inhibitory factor facilitates the therapeutic efficacy of mesenchymal stem cells derived exosomes in acute myocardial infarction through upregulating miR-133a-3p. J Nanobiotechnol. 2021;19(1):61. doi:10.1186/s12951-021-00808-5
   PubMed Web of Science ®Google Scholar
• Thery C, Witwer KW, Aikawa E, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7(1):1535750. doi:10.1080/20013078.2018.1535750
   PubMed Web of Science ®Google Scholar
• Vicencio JM, Yellon DM, Sivaraman V, et al. Plasma exosomes protect the myocardium from ischemia-reperfusion injury. J Am Coll Cardiol. 2015;65(15):1525–1536. doi:10.1016/j.jacc.2015.02.026
   PubMed Web of Science ®Google Scholar
• Li H, Liao Y, Gao L, et al. Coronary serum exosomes derived from patients with myocardial ischemia regulate angiogenesis through the miR-939-mediated nitric oxide signaling pathway. Theranostics. 2018;8(8):2079–2093. doi:10.7150/thno.21895
   PubMed Web of Science ®Google Scholar
• Pan Q, Wang Y, Lan Q, et al. Exosomes derived from mesenchymal stem cells ameliorate hypoxia/reoxygenation-injured ECs via transferring microRNA-126. Stem Cells Int. 2019:2831756. doi:10.1155/2019/2831756
   PubMed Web of Science ®Google Scholar
• Cao C, Wang B, Tang J, et al. Circulating exosomes repair endothelial cell damage by delivering miR-193a-5p. J Cell Mol Med. 2021;25(4):2176–2189. doi:10.1111/jcmm.16202
   PubMed Web of Science ®Google Scholar
• Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012;60(16):1581–1598. doi:10.1016/j.jacc.2012.08.001
   PubMed Web of Science ®Google Scholar
• Thomou T, Mori MA, Dreyfuss JM, et al. Adipose-derived circulating miRNAs regulate gene expression in other tissues. Nature. 2017;542(7642):450–455. doi:10.1038/nature21365
   PubMed Web of Science ®Google Scholar
• Zippel N, Ding Y, Fleming I. A modified aortic ring assay to assess angiogenic potential in vitro. Methods Mol Biol. 2016;1430:205–219. doi:10.1007/978-1-4939-3628-1_14
   PubMedGoogle Scholar
• Melo SA, Luecke LB, Kahlert C, et al. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature. 2015;523(7559):177–182. doi:10.1038/nature14581
   PubMed Web of Science ®Google Scholar
• Tian Y, Li X, Bai C, Yang Z, Zhang L, Luo J. MiR-17-5p promotes the endothelialization of endothelial progenitor cells to facilitate the vascular repair of aneurysm by regulating PTEN-mediated PI3K/AKT/VEGFA pathway. Cell Cycle. 2020;19(24):3608–3621. doi:10.1080/15384101.2020.1857958
   PubMed Web of Science ®Google Scholar
• Jin YP, Hu YP, Wu XS, et al. miR-143-3p targeting of ITGA6 suppresses tumour growth and angiogenesis by downregulating PLGF expression via the PI3K/AKT pathway in gallbladder carcinoma. Cell Death Dis. 2018;9(2):182. doi:10.1038/s41419-017-0258-2
   PubMed Web of Science ®Google Scholar
• He Q, Ye A, Ye W, et al. Cancer-secreted exosomal miR-21-5p induces angiogenesis and vascular permeability by targeting KRIT1. Cell Death Dis. 2021;12(6):576. doi:10.1038/s41419-021-03803-8
   PubMed Web of Science ®Google Scholar
• Mathiyalagan P, Liang Y, Kim D, et al. Angiogenic mechanisms of human CD34(+) stem cell exosomes in the repair of ischemic hindlimb. Circ Res. 2017;120(9):1466–1476. doi:10.1161/CIRCRESAHA.116.310557
   PubMed Web of Science ®Google Scholar
• Peter B, Crino KLN, Henske EP. The tuberous sclerosis complex. N Engl J Med. 2006;355:1345–1356.
   PubMed Web of Science ®Google Scholar
• Sun S, Chen S, Liu F, et al. Constitutive activation of mTORC1 in endothelial cells leads to the development and progression of lymphangiosarcoma through VEGF autocrine signaling. Cancer Cell. 2015;28(6):758–772. doi:10.1016/j.ccell.2015.10.004
   PubMed Web of Science ®Google Scholar
• Kenta Hirai DO, Fukushima Y, Kondo M, et al. Cardiosphere-derived exosomal microRNAs for myocardial repair in pediatric dilated cardiomyopathy. Sci Transl Med. 2020;12(573):8764. doi:10.1126/scitranslmed.abb3336
   Web of Science ®Google Scholar
• Yang H, Zhang H, Ge S, et al. Exosome-derived miR-130a activates angiogenesis in gastric cancer by targeting C-MYB in vascular endothelial cells. Mol Ther. 2018;26(10):2466–2475. doi:10.1016/j.ymthe.2018.07.023
   PubMed Web of Science ®Google Scholar
• Meng W, Hao Y, He C, Li L, Zhu G. Exosome-orchestrated hypoxic tumor microenvironment. Mol Cancer. 2019;18(1):57. doi:10.1186/s12943-019-0982-6
   PubMed Web of Science ®Google Scholar
• Geng T, Song Z, Xing J, Wang B, Dai S. Exosome derived from coronary serum of patients with myocardial infarction promotes angiogenesis through the miRNA-143/IGF-IR pathway. Int J Nanomedicine. 2020;15:2647–2658. doi:10.2147/ijn.S242908
   PubMed Web of Science ®Google Scholar
• McBride JD, Rodriguez-Menocal L, Badiavas EV. Extracellular vesicles as biomarkers and therapeutics in dermatology: a focus on exosomes. J Invest Dermatol. 2017;137(8):1622–1629. doi:10.1016/j.jid.2017.04.021
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhang X. Ischaemic preconditioning-induced serum exosomes protect against myocardial ischaemia/reperfusion injury in rats by activating the PI3K/AKT signalling pathway. Cell Biochem Funct. 2021;39(2):287–295. doi:10.1002/cbf.3578
   PubMed Web of Science ®Google Scholar
• Wang Y, Sun J, Kahaleh B. Epigenetic down-regulation of microRNA-126 in scleroderma endothelial cells is associated with impaired responses to VEGF and defective angiogenesis. J Cell Mol Med. 2021;25(14):7078–7088. doi:10.1111/jcmm.16727
   PubMed Web of Science ®Google Scholar
• Zhou Q, Anderson C, Hanus J, et al. Strand and cell type-specific function of microRNA-126 in angiogenesis. Mol Ther. 2016;24(10):1823–1835. doi:10.1038/mt.2016.108
   PubMed Web of Science ®Google Scholar
• Xue S, Liu D, Zhu W, et al. Circulating MiR-17-5p, MiR-126-5p and MiR-145-3p are novel biomarkers for diagnosis of acute myocardial infarction. Front Physiol. 2019;10:123. doi:10.3389/fphys.2019.00123
   PubMed Web of Science ®Google Scholar
• Ling H, Guo Z, Shi Y, Zhang L, Song C. Serum exosomal MicroRNA-21, MicroRNA-126, and PTEN are novel biomarkers for diagnosis of acute coronary syndrome. Front Physiol. 2020;11:654. doi:10.3389/fphys.2020.00654
   PubMed Web of Science ®Google Scholar
• Jakob P, Doerries C, Briand S, et al. Loss of angiomiR-126 and 130a in angiogenic early outgrowth cells from patients with chronic heart failure: role for impaired in vivo neovascularization and cardiac repair capacity. Circulation. 2012;126(25):2962–2975. doi:10.1161/CIRCULATIONAHA.112.093906
   PubMed Web of Science ®Google Scholar
• Yuan X, Deng X, Zhou X, et al. MiR-126-3p promotes the cell proliferation and inhibits the cell apoptosis by targeting TSC1 in the porcine granulosa cells. Vitro Cell Dev Biol Anim. 2018;54(10):715–724. doi:10.1007/s11626-018-0292-0
   PubMed Web of Science ®Google Scholar
• Marjon van Slegtenhorst MN, Nagelkerken B, Cheadle J, Snell R. Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products. Hum Mol Genet. 1998;7(6):1053–1057. doi:10.1093/hmg/7.6.1053
   PubMed Web of Science ®Google Scholar
• Huang J, Wu S, Wu CL, Manning BD. Signaling events downstream of mammalian target of rapamycin complex 2 are attenuated in cells and tumors deficient for the tuberous sclerosis complex tumor suppressors. Cancer Res. 2009;69(15):6107–6114. doi:10.1158/0008-5472.CAN-09-0975
   PubMed Web of Science ®Google Scholar
• Nisreen El-Hashemite VW, Zhang H, Kwiatkowski DJ. Loss of Tsc1 or Tsc2 induces vascular endothelial growth factor production through mammalian target of rapamycin. Cancer Res. 2003;63:5173–5177.
   PubMed Web of Science ®Google Scholar
• Foster KG, Fingar DC. Mammalian target of rapamycin (mTOR): conducting the cellular signaling symphony. J Biol Chem. 2010;285(19):14071–14077. doi:10.1074/jbc.R109.094003
   PubMed Web of Science ®Google Scholar
• Du W, Gerald D, Perruzzi CA, et al. Vascular tumors have increased p70 S6-kinase activation and are inhibited by topical rapamycin. Lab Invest. 2013;93(10):1115–1127. doi:10.1038/labinvest.2013.98
   PubMed Web of Science ®Google Scholar
• Shirazi F, Cohen C, Fried L, Arbiser JL. Mammalian target of rapamycin (mTOR) is activated in cutaneous vascular malformations in vivo. Lymphat Res Biol. 2007;5(4):233–236. doi:10.1089/lrb.2007.1012
   PubMedGoogle Scholar
• Rattner A, Williams J, Nathans J. Roles of HIFs and VEGF in angiogenesis in the retina and brain. J Clin Invest. 2019;129(9):3807–3820. doi:10.1172/JCI126655
   PubMed Web of Science ®Google Scholar
• Tian X, Liu Y, Wang Z, Wu S. miR-144 delivered by nasopharyngeal carcinoma-derived EVs stimulates angiogenesis through the FBXW7/HIF-1α/VEGF-A axis. Mol Therapy. 2021;24:1000–1011. doi:10.1016/j.omtn.2021.03.016
   Web of Science ®Google Scholar
• Song W, Liang Q, Cai M, Tian Z. HIF-1alpha-induced up-regulation of microRNA-126 contributes to the effectiveness of exercise training on myocardial angiogenesis in myocardial infarction rats. J Cell Mol Med. 2020;24(22):12970–12979. doi:10.1111/jcmm.15892
   PubMed Web of Science ®Google Scholar
• Xiaomin Nie LS, Zhou Y, Zhao Y. Association between plasma levels of microRNA-126 and coronary collaterals in patients with coronary artery disease. Chin J Cardiol. 2014;42(7):561–565.
   Google Scholar